Not provided
Not provided
Not provided
Not provided
Not provided
Low enrolment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to collect post-market clinical safety and performance data on the robotic assisted prophylactic Nipple Sparing Mastectomy (R-NSM) surgery performed with the da Vinci Xi/X Surgical System as part of a PMCF Plan.
This is an observational post-market study. Women will be screened for participation where the decision to undergo prophylactic R-NSM surgery has already been made as part of their medical care. In order for women to be enrolled, surgeons must perform the surgery according to the Instructions For Use (IFU) of da Vinci Xi/X Surgical System. Women will sign an informed consent form for their participation in the study. Women will be prospectively followed at 6 weeks, 3 months and 1 year post-surgery, which is within the standard of care. Data will be collected prospectively from the medical records and women will be asked to complete preoperative and postoperative questionnaires.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Prophylactic Nipple-Sparing Mastectomy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nipple-Sparing Mastectomy | Procedure | Nipple-Sparing Mastectomy using da Vinci X/Xi Surgical System |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of intraoperative R-NSM procedure and device-related complications | Assessed during surgery to 42 days after surgery | |
| Number of overall post-operative complications at 6 weeks | 6 weeks after the surgery | |
| Number of overall post-operative complications at 3 months | 3 months after the surgery | |
| Number of overall post-operative complications at 1 year | 1 year after the surgery | |
| Nipple-Areola Complex (NAC) necrosis occurrence (using SKIN composite score definition of D2 or higher) observed at 6 weeks after surgery | 6 weeks after surgery | |
| Nipple-Areola Complex (NAC) Preservation Rate at 6 weeks after surgery | 6 weeks after surgery | |
| Number of conversions to open surgery | Assessed during surgery | |
| OR & procedure (open surgery dissection, docking and console) times, including drainage and reconstruction times | Assessed during surgery to 6 weeks after surgery | |
| Number of transfusion and transfused units | Assessed during surgery to 6 weeks after surgery | |
| Hospital Length of Stay (LOS) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Women eligible for prophylactic robotic-assisted Nipple-Sparing Mastectomy (unilateral or bilateral) according to the Instructions For Use (IFU) of da Vinci Xi/X Surgical System
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Antonio Toesca, MD | Istituto Europeo di Oncologia | Principal Investigator |
| Benjamin Sarfati, MD | Gustave Roussy Cancer Campus | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Gustave Roussy Cancer Campus | Villejuif | 94800 | France | |||
| Istituto Europeo di Oncologia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Assessed during the 6 weeks after surgery |
| Results of the SKIN score (Mayo clinic) at 6 weeks or upon surgeon's practice | at 6 weeks or upon surgeon's practice |
| Number of readmissions associated with NSM surgery at 6 weeks | 6 weeks after surgery |
| Number of readmissions associated with NSM surgery at 3 months | 3 months after surgery |
| Number of reoperations associated with NSM surgery at 6 weeks | 6 weeks after surgery |
| Number of reoperations associated with NSM surgery at 3 months | 3 months after surgery |
| Result of BREAST-QTM (Quality of life) at 3 months | 3 months after surgery |
| Result of BREAST-QTM (Quality of life) at 1 year | 1 year after surgery |
| Result of NAC questionnaire (Quality of life) at 3 months | 3 months after surgery |
| Result of NAC questionnaire (Quality of life) at 1 year | 1 year after surgery |
| Breast Cancer Occurrence Assessment at 1 year according to usual medical practice | 1 year after surgery |
| Milan |
| 20141 |
| Italy |
| ID | Term |
|---|---|
| D015414 | Mastectomy, Subcutaneous |
| ID | Term |
|---|---|
| D008408 | Mastectomy |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided